These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 5139805

  • 1. [Curableness of Hodgkin's disease].
    Glińska H.
    Folia Med Cracov; 1971; 13(4):445-500. PubMed ID: 5139805
    [No Abstract] [Full Text] [Related]

  • 2. [Studies on the curability of Hodgkin's disease].
    Glińska H.
    Pol Tyg Lek; 1971 Apr 19; 26(16):591-5. PubMed ID: 5577333
    [No Abstract] [Full Text] [Related]

  • 3. Analysis of primary relapses after radiotherapy in Hodgkin's disease.
    Spittle MF, Harmer CL, Cassady JR, Kaplan HS.
    Natl Cancer Inst Monogr; 1973 May 19; 36():497-508. PubMed ID: 4744605
    [No Abstract] [Full Text] [Related]

  • 4. [Value of the 3d phase of lymphography in the assessment of the effectiveness of treatment of Hodgkin's disease].
    Dergachev AI.
    Probl Gematol Pereliv Krovi; 1979 Dec 19; 24(12):12-5. PubMed ID: 523445
    [No Abstract] [Full Text] [Related]

  • 5. [Prognostic disease symptoms and signs in Hodgkin's disease and their importance in the therapy of the disease].
    Musshoff K, Boutis L, Laszlo AM, Laszlo I.
    Strahlentherapie; 1966 Dec 19; 131(4):482-504. PubMed ID: 5992388
    [No Abstract] [Full Text] [Related]

  • 6. Relation of cell-mediated immunity to staging, histology and prognosis in untreated patients with Hodgkin's disease.
    De Gast GC, Halie MR.
    Neth J Med; 1976 Dec 19; 19(4-5):196-200. PubMed ID: 980187
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical characteristics of patients with Hodgkin's disease treated at the Institute of Oncology at Gliwice in the years 1947-1962].
    Slomska J, Rattka P.
    Pol Tyg Lek; 1970 Aug 10; 25(32):1210-2. PubMed ID: 5472550
    [No Abstract] [Full Text] [Related]

  • 8. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH, Wang SS, Huang Y, Wang B, Huang HQ, Zhang L, Sun XF, Xu RH, Lin TY.
    Ai Zheng; 2006 Aug 10; 25(8):1013-8. PubMed ID: 16965685
    [Abstract] [Full Text] [Related]

  • 9. Survival and relapse rates in Hodgkin's disease: Stanford experience, 1961-71.
    Kaplan HS.
    Natl Cancer Inst Monogr; 1973 May 10; 36():487-96. PubMed ID: 4126721
    [No Abstract] [Full Text] [Related]

  • 10. Hodgkin's disease clinical trial.
    Nickson JJ, Hutchison GB.
    Proc Natl Cancer Conf; 1970 May 10; 6():77-81. PubMed ID: 4989797
    [No Abstract] [Full Text] [Related]

  • 11. New vistas in Hodgkin's disease.
    Ioachim HL.
    Pathol Annu; 1975 May 10; 10():419-59. PubMed ID: 170577
    [No Abstract] [Full Text] [Related]

  • 12. Immunodeficiencies in Hodgkin's Disease. Part II: B cell immunity, complement systems and phagocytic cell systems.
    Gupta S.
    Clin Bull; 1981 May 10; 11(3):110-9. PubMed ID: 7039866
    [No Abstract] [Full Text] [Related]

  • 13. A review of Hodgkin's disease at the Cancer Institute, Madras.
    Shanta V, Sastri DV, Sagar TG, Sasikala K, Krishnamurthi S.
    Clin Oncol; 1982 Mar 10; 8(1):5-15. PubMed ID: 7075045
    [No Abstract] [Full Text] [Related]

  • 14. Impaired lymphocyte function in untreated Hodgkin's disease.
    Levy R, Kaplan HS.
    N Engl J Med; 1974 Jan 24; 290(4):181-6. PubMed ID: 4203007
    [No Abstract] [Full Text] [Related]

  • 15. Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure.
    Campbell B, Wirth A, Milner A, Di Iulio J, MacManus M, Ryan G.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1538-45. PubMed ID: 16125872
    [Abstract] [Full Text] [Related]

  • 16. Hodgkin's disease: a relationship of histology to other prognostic indicators.
    Witkowski F, Slomska J.
    Neoplasma; 1973 Dec 01; 20(4):437-42. PubMed ID: 4729140
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic factors in 454 cases of Hodgkin's disease.
    Tubiana M, Attié E, Flamant R, Gérard-Marchant R, Hayat M.
    Cancer Res; 1971 Nov 01; 31(11):1801-10. PubMed ID: 5121686
    [No Abstract] [Full Text] [Related]

  • 18. [Hodgkin's disease: clinical and hematological findings].
    Hofmann V, Berchtold H, Martz G.
    Schweiz Med Wochenschr; 1974 Feb 09; 104(6):204-8. PubMed ID: 4811567
    [No Abstract] [Full Text] [Related]

  • 19. Infective agents in the causation of Hodgkin's disease. A review of the epidemiological evidence.
    Abramson JH.
    Isr J Med Sci; 1973 Jul 09; 9(7):932-53. PubMed ID: 4354626
    [No Abstract] [Full Text] [Related]

  • 20. [Cellular immunity and clinico-histological stage in Hodgkin's disease].
    Fabris C, De Sanctis C, Ciriotti G, Ponzone A.
    Minerva Pediatr; 1971 Feb 04; 23(5):190-3. PubMed ID: 5574421
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.